Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Heinrich

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
The Lancet. Oncology|September 25, 2010
Imatinib treatment of metastatic GIST: don't stop (believing)Michael C Heinrich
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Is KIT an important therapeutic target in small cell lung cancer?Michael C Heinrich
Mini Reviews in Medicinal Chemistry|March 23, 2004
Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospectsMichael C Heinrich
Cell|February 11, 2017
PDGFRA Antibody for Soft Tissue SarcomaLillian R Klug, Michael C Heinrich
Annual Review of Pathology|November 28, 2007
Molecular pathobiology of gastrointestinal stromal sarcomasChristopher L Corless, Michael C Heinrich
Journal of Surgical Oncology|May 17, 2005
Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapyMichael C Heinrich, Christopher L Corless
Nature Clinical Practice. Oncology|November 3, 2006
Does tumor mutational status correlate with clinical response to imatinib?Michael C Heinrich, Christopher L Corless
Seminars in Diagnostic Pathology|March 14, 2015
Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An updateBrian P Rubin, Michael C Heinrich
Nature|October 15, 2010
Cancer: Oncogenes in contextMichael C Heinrich, Christopher L Corless
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Management of tyrosine kinase inhibitor-resistant gastrointestinal stromal tumorsChristine M Barnett, Michael C Heinrich
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|September 25, 2010
Imatinib treatment of metastatic GIST: don't stop (believing)Michael C Heinrich
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Is KIT an important therapeutic target in small cell lung cancer?Michael C Heinrich
Mini Reviews in Medicinal Chemistry|March 23, 2004
Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospectsMichael C Heinrich
Cell|February 11, 2017
PDGFRA Antibody for Soft Tissue SarcomaLillian R Klug, Michael C Heinrich
Annual Review of Pathology|November 28, 2007
Molecular pathobiology of gastrointestinal stromal sarcomasChristopher L Corless, Michael C Heinrich
Journal of Surgical Oncology|May 17, 2005
Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapyMichael C Heinrich, Christopher L Corless
Nature Clinical Practice. Oncology|November 3, 2006
Does tumor mutational status correlate with clinical response to imatinib?Michael C Heinrich, Christopher L Corless
Seminars in Diagnostic Pathology|March 14, 2015
Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An updateBrian P Rubin, Michael C Heinrich
Nature|October 15, 2010
Cancer: Oncogenes in contextMichael C Heinrich, Christopher L Corless
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Management of tyrosine kinase inhibitor-resistant gastrointestinal stromal tumorsChristine M Barnett, Michael C Heinrich
Pageof 23